Read More Pharma Industry News Stability data and strategy: PharmAla Biotech Holdings Inc. builds commercial groundwork for LaNeo MDMA PharmAla Biotech Holdings Inc. launches a three-year stability program for LaNeo MDMA. Discover how this could reshape psychedelic drug commercialization. bySoujanya RaviFebruary 26, 2026